Related Experiment Video

Updated: May 21, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.6K

Designing molecular hybrids as novel breast cancer therapeutics

Shagufta1, Irshad Ahmad1, Noora Ali Nasar1

  • 1Department of Biotechnology, School of Arts and Sciences, American University of Ras Al Khaimah, Ras Al Khaimah, United Arab Emirates.

Future Medicinal Chemistry
|March 18, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Breast canceranti-breast cancerhybrid moleculesmolecular hybridstamoxifen hybrids

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.4K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.5K

Related Experiment Videos

Last Updated: May 21, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.6K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.4K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

Articles linked to this work by shared authors, journal, and citation graph.

Benchmarking Class Imbalance Mitigation Strategies Across Deep CNN Architectures for Skin Cancer Classification.

Diagnostics (Basel, Switzerland)·2026

XHIC-Net: An Explainable Hybrid Involution-Convolution Network for Blood Smear Cell Morphology Classification.

Bioengineering (Basel, Switzerland)·2026

Advances in the clinical application of mesenchymal stem cells for neurological disorders.

Stem cell research & therapy·2026

Effects of a Virtual Reality-Based Balance Training Program on Clinical Outcomes and Cortical Oscillatory Activity: A Combined Behavioral and EEG Study.

NeuroRehabilitation·2026

Advances in quercetin-based therapeutics for breast cancer: natural, synthetic, and nanotechnology-driven approaches.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026

Gait asymmetry as a determinant of functional recovery and return to sport after ACL reconstruction: a cross-sectional biomechanical analysis.

Frontiers in bioengineering and biotechnology·2026

Integrated in vitro and in silico evaluations of novel benzanilide derivatives as anticancer agents.

Future medicinal chemistry·2026

Synthesis of benzenesulfonamide derivatives reveals anti-CCSCs activity by regulating Wnt/β-catenin pathway.

Future medicinal chemistry·2026

Rational drug design, synthetic and artificial intelligence approaches for bioactive heterocycles: advances and perspectives.

Future medicinal chemistry·2026

EGFR kinase inhibitors from novel thiazole derivatives: synthesis, anticolon cancer, docking, and ADME studies.

Future medicinal chemistry·2026

VEGFR-2 as a druggable target: recent advances (2025) in the development of five-membered heterocyclic anticancer agents.

Future medicinal chemistry·2026

Latest developments of spirooxindoles and their derivatives in medicinal chemistry.

Future medicinal chemistry·2026

A universally conserved OMV-YidR conjugate nanovaccine confers broad protection against hypervirulent and carbapenem-resistant Klebsiella pneumoniae.

Emerging microbes & infections·2026

N-Myristoylation: A Central Hub Integrating Tumor Signaling, Metabolism, and Immunity for Precision Therapy.

Medicinal research reviews·2026

Unlocking the hidden DNAzyme repertoire through aptamer-gated exonuclease signal amplification.

Chemical communications (Cambridge, England)·2026

Intranasal administration of spike-specific mRNA-LNP confers more protection than the intramuscular route against SARS-CoV-2.

Iranian journal of basic medical sciences·2026

Evaluation of Posttreatment Eradication Testing Following Helicobacter pylori Therapy.

The Permanente journal·2026

Bridging the Gap: How technology and AI are making clinical trial participation accessible and practical for community physicians.

Journal of the National Medical Association·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us